BCAN launched its Bladder Cancer Young Investigator Awards in 2013 to support outstanding early-career scientists and clinical cancer researchers with a demonstrated commitment to improving the understanding and treatment of bladder cancer and/or upper tract urothelial cancer. Applicants may be working in basic, translational, clinical, epidemiologic, bioengineering sciences or any other field, but projects must be specific to bladder cancer and/or upper tract urothelial carcinoma, and the applicant’s research environment must be capable of supporting transformational bladder cancer research.

The Patient-Centered Clinical Research Young Investigator Award (PCC-YIA) supports early-career scientists and clinical cancer researchers investigating transformational patient-oriented clinical bladder cancer and/or upper tract urothelial cancer research (e.g. studies of shared decision making, access to care, quality of care, quality of life, health disparities, comparative effectiveness research, patient-centered outcomes research, and survivorship).

Deadline: Feb. 22, 2023